DELSTRIGO
DELSTRIGO
Approved
DIN Number
02482592
Drug Class
Human
Market Date
Dec 10, 2018
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02482592
AIG Number0360870001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR24 LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (3)
DORAVIRINEActive
Strength: 100 MG
Monograph: DORAVIRINE
LAMIVUDINEActive
Strength: 300 MG
Monograph: LAMIVUDINE
TENOFOVIR DISOPROXIL FUMARATEActive
Strength: 300 MG
Monograph: TENOFOVIR DISOPROXIL FUMARATE